Kala Bio Inc (KALA)

Apr 14, 2025

Oppenheimer maintains Kala Bio stock Outperform with $15 target By Investing.com - Investing.com Canada

Apr 14, 2025

Apr 11, 2025

Kala Bio announces executive retention bonuses - Investing.com Australia

Apr 11, 2025

Apr 11, 2025

KALA stock touches 52-week low at $3.4 amid market challenges By Investing.com - Investing.com South Africa

Apr 11, 2025

Apr 11, 2025

Kala Bio announces executive retention bonuses By Investing.com - Investing.com South Africa

Apr 11, 2025

Apr 11, 2025

Kala Pharmaceuticals Announces Executive Retention Agreements - TipRanks

Apr 11, 2025

Apr 11, 2025

KALA stock touches 52-week low at $3.4 amid market challenges - Investing.com

Apr 11, 2025

Apr 06, 2025

Dynatrace, Inc. (NYSE:DT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Apr 06, 2025

Apr 06, 2025

Darling Ingredients Inc. (NYSE:DAR) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Apr 06, 2025

Apr 06, 2025

Truist Financial Lowers Bank of New York Mellon (NYSE:BK) Price Target to $90.00 - Defense World

Apr 06, 2025

Apr 06, 2025

HC Wainwright Reaffirms “Buy” Rating for KALA BIO (NASDAQ:KALA) - Defense World

Apr 06, 2025

Apr 04, 2025

Kala Pharmaceuticals stock hits 52-week low at $4.05 - Investing.com India

Apr 04, 2025

Apr 04, 2025

Kala Pharmaceuticals stock hits 52-week low at $4.05 By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

H.C. Wainwright maintains Buy on Kala Bio, target at $15 By Investing.com - Investing.com Canada

Apr 04, 2025

Apr 02, 2025

Kala Bio Inc Reports Q4 2024 Earnings: EPS Misses Estimate at -2 - GuruFocus

Apr 02, 2025

Apr 02, 2025

Simply Good Foods (SMPL) Expected to Announce Earnings on Wednesday - The AM Reporter

Apr 02, 2025

Apr 01, 2025

Oppenheimer maintains Outperform on Kala Pharmaceuticals stock - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

Oppenheimer maintains Outperform on Kala Pharmaceuticals stock By Investing.com - Investing.com UK

Apr 01, 2025

Apr 01, 2025

KALA BIO: Q4 Earnings Snapshot - Huron Daily Tribune

Apr 01, 2025

Apr 01, 2025

KALA BIO Advances Eye Disease Therapies with New Funding - TipRanks

Apr 01, 2025

Mar 31, 2025

KALA BIO Inc. (KALA) reports earnings - Quartz

Mar 31, 2025

Mar 31, 2025

KALA BIO, Inc. SEC 10-K Report - TradingView

Mar 31, 2025

Mar 31, 2025

KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - TradingView

Mar 31, 2025

Mar 28, 2025

North American Morning Briefing : Tariff Jitters -2- - Marketscreener.com

Mar 28, 2025

Mar 28, 2025

KALA BIO (KALA) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025

Mar 25, 2025

KALA BIO Inc expected to post a loss of $2.28 a shareEarnings Preview - TradingView

Mar 25, 2025

Mar 25, 2025

Comprehensive Insights of the Global Acute Ocular Pain Market: Key Drivers, Trends, Growth Opportunities, a... - WhaTech

Mar 25, 2025

Mar 20, 2025

KALA BIO (KALA) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 20, 2025

Feb 26, 2025

Kala Bio appoints new interim CEO amid leadership shuffle - MSN

Feb 26, 2025

Feb 26, 2025

KALA BIO to Present at TD Cowen 45th Annual Health Care Conference - TradingView

Feb 26, 2025

Feb 26, 2025

BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million - The Manila Times

Feb 26, 2025

Feb 26, 2025

What Will KALA BIO Reveal at the TD Cowen Healthcare Conference Next Week? - StockTitan

Feb 26, 2025

Feb 26, 2025

Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction - MSN

Feb 26, 2025

Feb 19, 2025

Precision Bio stock gains on Hep B drug data (DTIL:NASDAQ) - Seeking Alpha

Feb 19, 2025

Feb 18, 2025

Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company's Growth - The Manila Times

Feb 18, 2025

Feb 18, 2025

Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth - GlobeNewswire

Feb 18, 2025

Feb 18, 2025

Major Leadership Shake-up: Pharma Veteran Takes Helm at Inhibikase with $110M War Chest - StockTitan

Feb 18, 2025

Feb 18, 2025

KALA BIO's (KALA) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Feb 18, 2025

Feb 17, 2025

Kala Bio Inc (NASDAQ: KALA) Has Been Trading Down. What Are The Prospects For The Future? - Stocks Register

Feb 17, 2025

Feb 15, 2025

KALA BIO says CEO Mark Iwicki resigns - MSN

Feb 15, 2025